Overview


According to FutureWise analysis the market for in vitro fertilization /IVF in 2023 is US$ 0.75 billion, and is expected to reach US$ 1.54 billion by 2031 at a CAGR of 9.32%.

Fertilization of egg cells by sperm in a laboratory dish, followed by implantation in a woman's uterus, is called in vitro fertilization (IVF). Assisted reproductive technology is a type of assisted reproduction used to deal with fertility problems or genetic problems so that a child can be conceived. A process of fertilization that includes retrieval and extraction of sperm cells, as well as manual mixing of eggs and sperm in a laboratory setting to form an embryo. Once the embryos have been transferred, they continue to develop in the uterus. IVF can be done in two ways, such as through insemination or intracytoplasmic sperm injection (ICSI). This treatment is performed with a variety of machines, including incubators, microscopes, IVF disposables, ultrasound machines, and other devices. An IVF procedure consists of several steps, and the entire process usually takes several months to complete. Many women need more than one round of IVF in order to become pregnant. Sometimes IVF works the first time. IVF increases the chances of pregnancy if you have fertility problems, but there are no guarantees, everyone's body is different, so IVF may not work for you. There are unusual risks and possible side effects associated with IVF, as with all medications and medical procedures. As well as being physically challenging, it can also be emotionally challenging for the person receiving the procedure, as well as their partners and/or families. As a result of lifestyle changes and increasing trends in assisted reproductive technology, the global market for in vitro fertilization is largely driven by increasing infertility rates. Additionally, an escalating number of ovulation disorders and the practice of preimplantation genetic screenings or diagnosis in the healthcare sector may contribute to the growth of the In Vitro Fertilization market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of In Vitro Fertilization /IVF Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the In Vitro Fertilization /IVF Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • The Cooper Companies Inc.
  • Cook Group
  • Vitrolife
  • Thermo Fisher Scientific, Inc.
  • Esco Micro Pte. Ltd.
  • Genea Limited
  • IVFtech ApS
  • FUJIFILM Irvine Scientific
  • The Baker Company, Inc.
  • Kitazato Corporation
  • Rocket Medical plc.
  • Hamilton Thorne Ltd.
  • ZEISS Group
  • FERTIPRO NV
  • Gynotec B.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Equipment
    • Sperm Analyzer Systems
    • Imaging Systems
    • Ovum Aspiration Pumps
    • Micromanipulator Systems
    • Incubators
    • Gas Analyzers
    • Laser Systems
    • Cryosystems
    • Sperm Separation Devices
    • IVF Cabinets
    • Anti-vibration Tables
    • Witness Systems
    • Other Equipment
  • Reagents and Media
    • Cryopreservation Media
    • Embryo Culture Media
    • Ovum Processing Media
    • Sperm Processing Media
  • Accessories

By Cycle

  • Fresh Non-donor IVF Cycles
  • Frozen Non-donor IVF Cycles
  • Frozen Donor IVF Cycles
  • Fresh Donor IVF Cycle

By Type

  • Conventional IVF
  • IVF with ICSI
  • IVF with Donor Eggs
  • Others

By End User

  • Fertility Clinics
  • Hospitals and Surgical Centers
  • Cryobanks
  • Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the In Vitro Fertilization /IVF Market By Product, By Cycle, By Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansion

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   In Vitro Fertilization /IVF Market Variables, Trends and Scope
    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of In Vitro Fertilization /IVF Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   In Vitro Fertilization /IVF Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   In Vitro Fertilization /IVF Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Equipment
         1.1. Sperm Analyzer Systems
         1.2. Imaging Systems
         1.3. Ovum Aspiration Pumps
         1.4. Micromanipulator Systems
         1.5. Incubators
         1.6. Gas Analyzers
         1.7. Laser Systems
         1.8. Cryosystems
         1.9. Sperm Separation Devices
         1.10. IVF Cabinets
         1.11. Anti-vibration Tables
         1.12. Witness Systems
         1.13. Other Equipments
        2. Reagents and Media
         2.1. Cryopreservation Media
         2.2. Embryo Culture Media
         2.3. Ovum Processing Media
         2.4. Sperm Processing Media
        3. Accessories

  • 8.   In Vitro Fertilization /IVF Market, By Cycle Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Fresh Non-donor IVF Cycles
        2. Frozen Non-donor IVF Cycles
        3. Frozen Donor IVF Cycles
        4. Fresh Donor IVF Cycle

  • 9.   In Vitro Fertilization /IVF Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Conventional IVF
        2. IVF with ICSI
        3. IVF with Donor Eggs
        4. Others

  • 10.   In Vitro Fertilization /IVF Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Fertility Clinics
        2. Hospitals and Surgical Centers
        3. Cryobanks
        4. Research Institutes

  • 11.   North America In Vitro Fertilization /IVF Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America In Vitro Fertilization /IVF Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe In Vitro Fertilization /IVF Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific In Vitro Fertilization /IVF Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. The Cooper Companies Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cook Group
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Vitrolife
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Thermo Fisher Scientific, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Esco Micro Pte. Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Genea Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. IVFtech ApS
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. FUJIFILM Irvine Scientific
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. The Baker Company, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
             10. Kitazato Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
             11. Rocket Medical plc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
             12. Hamilton Thorne Ltd.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
             13. ZEISS Group
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
             14. FERTIPRO NV
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
           15. Gynotec B.V.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients